Tamoxifen and Hormone Replacement Therapy Effects on Heart Health
Author Information
Author(s): A Decensi, C Robertson, N Rotmensz, G Seven, P Maisonneuve, V Sacchini, P Boyle, A Costal, U Veronesi
Primary Institution: European Institute of Oncology
Hypothesis
Does the combination of tamoxifen and hormone replacement therapy affect cardiovascular risk factors?
Conclusion
Tamoxifen's beneficial effects on cardiovascular risk factors are maintained in women already using hormone replacement therapy, but may be reduced in those who start hormone therapy during tamoxifen treatment.
Supporting Evidence
- Tamoxifen reduced total cholesterol by approximately 9% in both HRT users and non-users.
- The reduction in LDL cholesterol was similar across both groups.
- Women who started HRT during tamoxifen treatment experienced a reduced effect on cholesterol levels.
Takeaway
This study looked at how a medicine for breast cancer and hormone therapy work together. It found that if women were already using hormone therapy, the breast cancer medicine still worked well, but starting hormone therapy while on the medicine might make it less effective.
Methodology
The study involved a prevention trial where women were randomized to receive either tamoxifen or placebo, with blood measurements taken at baseline and 12 months.
Potential Biases
Women on HRT may have been selected based on higher cholesterol levels, potentially skewing results.
Limitations
The study was observational and not randomized for HRT use, which may introduce selection bias.
Participant Demographics
Women aged 35 to 70, with a history of hysterectomy for non-malignant conditions.
Statistical Information
P-Value
0.051
Statistical Significance
p=0.051
Want to read the original?
Access the complete publication on the publisher's website